Investment Q&A

Q: there's some fringe companies doing experiments with magic mushrooms to treat anxiety, depression and a number of other ailments. If this takes off do you think this could have lots of upside , or will this be attacked by large drug makers whose patented drugs could loose market share ? Thanks alot.

Q: Please comment on earnings

Q: Hi,
If choosing between Pfizer and Merck today for a long term hold (5-10 years), which would you choose and why please. Thanks very much.
Michael

Q: To me WELL is hitting on all cylinders but it is unloved within the market. This from it's latest results:

WELL reported record quarterly revenues of $126.5 million in Q1-2022 representing a 395% year-over-year (YoY) increase compared to Q1-2021, catapulting the Company to over $500 million annualized revenue run-rate. Revenues reflected accelerating organic growth to 15% on a YoY basis

I have held it for a while now and am under water. Granted we are in a down market but do you think this stock will get more attention once the market hits bottom [when ever that is] and starts to move up?

Thanks

Q: will SIS be able to keep paying dividends? Thanks.

Q: Please comment on Savaria Corps earnings. Thanks.

Q: Your comment on the last result .

Thank you

Q: Please comment on its earnings. How do you think it is as a long term holding?

Q: what does the market expect from savaria this quarter?

Thx

Q: In an answer today you stated '20% of biotech companies in the US now trading below cash levels'. What would be your top biotech picks and/or your top biotech ETFs to play a recovery?

Q: INMD looks cheap at this price. What am I missing? Why is it being hit harder than the markets?

Q: In one of your responses you stated "But, there are good signs, such as 20% of biotech companies in the US now trading below cash levels". If this is net cash (i.e. after debt), wouldn't these be great buying opportunities, assuming the companies are solid. They would eventually trade at their cash position (at minimum, I would have to believe). If my thesis is correct, can you name a few of these companies. I think this may be pretty much a sure thing?

Q: These two companies are incredibly innovative and have developed the vaccines that save us all. They are very profitable with Moderna selling at a PE of 5 and BioNtech at a PE of 3.2. Yet they continue to go down. They also have quite a few medicines in their pipelines. I have 65 shares of MRNA in my TFSA. Your thoughts?

Q: Hi Folks
I am looking to add to my Health Sector, currently holding ABBV, PFE, GILD and WELL in various accounts. I have CVS and MRK in mind to add - which one would you recommend at this time and why ? Appreciate your comments.
Thanks

Q: Can you please rank the following cancer related stocks based from best to worst based on your understanding of which are currently under appreciated based on their potential to cure or prevent cancer? To put it another way, do any of them have technology that could become significantly larger businesses than they are today in treating or detecting cancer?
Please add one name that I have not listed that may have higher potential.

Q: I think I may have timed out before submitting this question earlier.

I wanted to know your views on swapping DHR for ISRG in my health care allocation, which currently includes SYK and WELL. I know you like ISRG today, perhaps more than you did a couple of years ago when you had concerns about their business in China. Is China a significant part of their business? And your DHR concerns seem centred on their higher levels of debt which are being paid down.

I have done well with DHR but I am wondering if ISRG's growth profile is considered higher without taking on a significant increase in risk. Or would one of my other holdings be a better swap? Or is "do nothing" the best course?

Appreciate your insight.


Paul F.

Q: At the time of writing, PRN is up by 10% today. Deeply under water, earnings next week. What to expect? Is it a keeper for the next year or should I sell for tax loss and take my money elsewhere? If a sell, would you wait for earnings? The market is so short term sighted that with COVID PRN might suffer for an extend period of time.

Q: What do feel are the best bargains currently in this market ? Top 10 please, and a management ranking, 10 being the best. Long time time horizon. Thanks

Also, please provide your favourite Cnd stock/ETF for an RESP. Long time horizon

Thanks

Nick

Q: Good morning 5i,
I have a loss in Gild and have been waiting for a time to claim it and buy a replacement. It seems to me that the recent drop in Abbivie might provide that opportunity, unless there is something I don't see. Would you think that this would be the best opportunity in this field at the moment?
thanks as always for your great work

Q: Your thoughts on ABBV's quarter?